Search

This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America. [ABSTRACT FROM AUTHOR]

The article talks about Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) for the prevention of Lyme disease and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens.

The article focuses on the characteristics, diagnosis and treatment of the tick-borne infection Lyme disease. Topics discussed include the clinical manifestations of the disease, the role of parasitic insects in spreading the disease, bodily signs that may indicate the presence of the disorder and the recommended method for the diagnosis and treatment.

The author offers insights on the use of diagnostic method xenodiagnosis for addressing the symptoms related problem associated with posttreatment lyme disease syndrome in context to the related study carried by researcher Marques A. The topics discussed include concerns regarding the use of xenodiagnosis for detecting persistence of bacterial specie Borrelia burgdorferi in humans, use of animal models for the study, and human study model for detection of Borrelia burgdorferi infection.

The article presents an obituary for Stephen E. Malawista, professor of medicine at Yale University in Connecticut and former president of the American College of Rheumatology.